Hjerte-magnetisk resonans (HMR) er en stråle-fri scanningsteknik, der giver den bedste standard til evaluering af hjertets anatomi, funktion og endda vævssammensætning. I RESILIENCE-forsøget anvendes HMR som den primære metode, og patienter vil i forsøgspersioden modtage 3 af disse scanninger.
RESILIENCE-forsøget er et multinationalt, prospektivt, proof-of-concept fase II, dobbeltblindet, sham-kontrolleret, randomiseret klinisk forsøg (RCT) til at evaluere effekten og sikkerheden af fjern iskæmisk prækonditionering (RIC) hos patienter med Lymfom der modtager kræftbehandling med antracykliner. Forsøgsdeltagelse forudsætter ≥5 planlagte kemoterapibehandlinger.
On Friday May 12th our RESILIENCE Steering Committee and General Assembly session were held at the National Center for Cardiovascular Research (CNIC) in Madrid. The meetings counted on the support of all the partners of the project financed by the European Commission, both national and international, as well as members
It is a great satisfaction for us to inform you that on Monday April 17th Hospital General Universitario Gregorio Marañón in Madrid has joined the RESILIENCE project. The Hospital will begin to recruit patients in the coming weeks with the aim of strengthening the hearts of people undergoing cancer treatment
RESILIENCE grows every day with the incorporation of new centers that expand the network of influence of our project, whose objective is to help people undergoing cancer treatment with anthracyclines to continue their lives with a strong heart. The latest addition has been the Hospital Universitario Virgen de las Nieves
On Tuesday March 14th we met with a team of Virgen del Rocío University Hospital in Seville to share the training of our RESILIENCE project and thus begin its recruitment of patients. Four experts from our project, Irene Sempere, Noemí Escalera, Andrea Moreno and Javier Sánchez, met with the specialists
We are happy to announce that the Henri Becquerel Center in France is now open for patient recruitment. Congratulations to the whole team! A total of 9 Spanish and European hospitals are already collaborating with the project, which translates into a greater scope of the benefits that this therapy can
We have interviewed Dr. Raúl Córdoba, MD, PhD. Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, Madrid, Spain. Chair of the EHA Scientific Working Group. Thanks to the advances we have made, especially in the last decade, in new treatment options for cancer patients, we have
RESILIENCE-forsøget er et multinationalt, prospektivt, proof-of-concept fase II, dobbeltblindet, sham-kontrolleret, randomiseret klinisk forsøg (RCT) til at evaluere effekten og sikkerheden af fjern iskæmisk prækonditionering .
